Literature DB >> 12515996

Expression of CD44s in human colorectal cancer.

Mousa Khoursheed1, T C Mathew, R R Makar, L Sonia, H Abul, S Asfar, H Al-Sayer, H M Dashti, A Al-Bader.   

Abstract

CD44s is a cell adhesion molecule, which belongs to the family of hyaluronan binding proteins. Anti-body to CD44s is used to establish the association of its expression with the clinicopathological characteristics of colorectal cancer using immunohistochemical methods. The aim of this study is to investigate the expression of the standard form of CD44 (CD44s) in colorectal cancer tissues as compared to adjacent normal colonic tissues. Furthermore, the level of expression of CD44s in colorectal cancer tissues was correlated with the degree of histological differentiation, Duke s classification, sex, size and site of the tumor. Immunohistochemical analysis for CD44s was carried out in 49 paraffin-fixed sections of neoplastic colorectal tissues and non-neoplastic ones adjacent to the lesion, by the standard peroxidase-antiperoxidase method. Expression of these antigens were compared in normal and malignant epithelium and stromal cells. The results show that the level of CD44s in the epithelial and stromal cells was significantly higher in the colorectal cancer tissues than the normal ones. However, there was no association between the percentages of expressions of CD44s and the degree of histological differentiation, Duke s classification, sex or size of the tumor. There was however, a significantly higher expression of CD44s in the epithelium of rectal cancer than that of colonic cancer. This study indicates that the expression of CD44s is significantly higher in colorectal cancer tissues. However, further studies are required to understand its role in tumor progression and metastasis of this disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12515996     DOI: 10.1007/bf03032390

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  26 in total

1.  Biochemical characterization and cellular distribution of a polymorphic, murine cell-surface glycoprotein expressed on lymphoid tissues.

Authors:  I S Trowbridge; J Lesley; R Schulte; R Hyman; J Trotter
Journal:  Immunogenetics       Date:  1982-03       Impact factor: 2.846

2.  Progressive loss of CD44 gene expression in invasive bladder cancer.

Authors:  T Sugino; H Gorham; K Yoshida; J Bolodeoku; V Nargund; D Cranston; S Goodison; D Tarin
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

3.  Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis.

Authors:  K M Ropponen; M J Eskelinen; P K Lipponen; E Alhava; V M Kosma
Journal:  Scand J Gastroenterol       Date:  1998-03       Impact factor: 2.423

4.  A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells.

Authors:  U Günthert; M Hofmann; W Rudy; S Reber; M Zöller; I Haussmann; S Matzku; A Wenzel; H Ponta; P Herrlich
Journal:  Cell       Date:  1991-04-05       Impact factor: 41.582

5.  Expression of CD44R1 adhesion molecule in colon carcinomas and metastases.

Authors:  K K Tanabe; L M Ellis; H Saya
Journal:  Lancet       Date:  1993-03-20       Impact factor: 79.321

6.  Transitional mucosa of the colon and tumor growth factors.

Authors:  C R Boland; Y S Kim
Journal:  Med Hypotheses       Date:  1987-03       Impact factor: 1.538

7.  Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.

Authors:  G R Screaton; M V Bell; D G Jackson; F B Cornelis; U Gerth; J I Bell
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

Review 8.  The role of CD44 splice variants in human metastatic cancer.

Authors:  J Sleeman; J Moll; L Sherman; P Dall; S T Pals; H Ponta; P Herrlich
Journal:  Ciba Found Symp       Date:  1995

9.  Expression of variant CD44-messenger RNA in colorectal adenocarcinomas and adenomatous polyps in humans.

Authors:  F Imazeki; O Yokosuka; T Yamaguchi; M Ohto; K Isono; M Omata
Journal:  Gastroenterology       Date:  1996-02       Impact factor: 22.682

10.  Prevention of tumor metastasis formation by anti-variant CD44.

Authors:  S Seiter; R Arch; S Reber; D Komitowski; M Hofmann; H Ponta; P Herrlich; S Matzku; M Zöller
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

View more
  5 in total

1.  Evaluation of CD44s, CD44v6, CXCR2, CXCL1, and IL-1β in Benign and Malignant Tumors of Salivary Glands.

Authors:  Fonthip Laohavisudhi; Titikorn Chunchai; Natnicha Ketchaikosol; Wacharaporn Thosaporn; Nipon Chattipakorn; Siriporn C Chattipakorn
Journal:  Diagnostics (Basel)       Date:  2022-05-20

Review 2.  Hyaluronan: genetic insights into the complex biology of a simple polysaccharide.

Authors:  John A McDonald; Todd D Camenisch
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

3.  Detection of Cancer Stem Cells in Colorectal Cancer: Histopathological and Immunohistochemical Study.

Authors:  Nour El Hoda S Ismaiel; Walid M Sharaf; Dina O Helmy; Mona M Zaki; Manal A Badawi; Ahmed S A Soliman
Journal:  Open Access Maced J Med Sci       Date:  2016-12-07

4.  Characteristics of CD44 alternative splice pattern in the course of human colorectal adenocarcinoma progression.

Authors:  Balázs Bánky; Lívia Rásó-Barnett; Tamás Barbai; József Tímár; Péter Becságh; Erzsébet Rásó
Journal:  Mol Cancer       Date:  2012-11-14       Impact factor: 27.401

5.  Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.

Authors:  Qiong Wu; Yan Yang; Shiwu Wu; Wanyun Li; Na Zhang; Xiuqin Dong; Yurong Ou
Journal:  Diagn Pathol       Date:  2015-09-25       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.